AcoArt III / Arterio-venous Fistula in China

NACompletedINTERVENTIONAL
Enrollment

244

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

July 7, 2022

Conditions
Arteriovenous Fistula Stenosis
Interventions
DEVICE

drug-coated balloon catheter (Orchid, Acotec)

After predilation, using drug-coated balloon catheter to cover the whole treated segment

DEVICE

plain balloon catheter (Admiral, medtronic)

After predilation, using plain balloon catheter to cover the whole treated segment

Trial Locations (13)

Unknown

Chinese PLA General Hospital, Beijing

Tongren hospital, Capital medical university, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Guangdong provincial people's hospital, Guangzhou

Nanfang hospital, Guangzhou

The first hospital of Hebei medical university, Shijiangzhuang

The first hospital of Chinese medical university, Harbin

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

The first hospital of Jilin medical university, Changchun

Renji Hospital ShangHai Jiaotong University School Of Medicine, Shanghai

Shaoyifu hospital, zhejiang medical universiyt, Hangzhou

Zhejiang provincial people's hospital, Hangzhou

Beijing Friendship Hospital,Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Acotec Scientific Co., Ltd

INDUSTRY

NCT03366727 - AcoArt III / Arterio-venous Fistula in China | Biotech Hunter | Biotech Hunter